{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:34:39Z","timestamp":1791729279678,"version":"4.3.4"},"publisher-location":"Chichester, UK","reference-count":176,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003868.pub3","type":"reference-entry","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T13:52:50Z","timestamp":1374673970000},"source":"Crossref","is-referenced-by-count":37,"title":["Oral morphine for cancer pain"],"prefix":"10.1002","author":[{"given":"Philip J","family":"Wiffen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bee","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,7,23]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD003868.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0885-3924(97)00082-1","article-title":"Transdermal fentanyl versus sustained-release oral morphine in cancer","volume":"13","author":"Ahmedzai","year":"1997","journal-title":"Journal of Pain and Symptom Management"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub3-BIB2|cit2","first-page":"653","article-title":"Control of severe pain with sustained-release morphine tablets versus oral morphine solution","volume":"140","author":"Arkinstall","year":"1989","journal-title":"Canadian Medical Association Journal"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD003868.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/1097-0142(19890601)63:11<2294::AID-CNCR2820631139>3.0.CO;2-X","article-title":"Analgesic response to single and multiple doses of controlled release morphine tablets and morphine oral solution in cancer patients","volume":"63","author":"Goughnour","year":"1989","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/j.1552-4604.1998.tb04380.x","article-title":"Comparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer pain","volume":"38","author":"Babul","year":"1998","journal-title":"Journal of Clinical Pharmacology"},{"issue":"7","key":"10.1002\/14651858.CD003868.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0885-3924(92)90018-D","article-title":"A comparative study of controlled-release morphine (CRM) suspension and CRM tablets in chronic cancer pain","volume":"7","author":"Boureau","year":"1992","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(97)00012-2","article-title":"Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain","volume":"14","author":"Broomhead","year":"1997","journal-title":"Journal of Pain and Symptom Management"},{"issue":"10","key":"10.1002\/14651858.CD003868.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1200\/JCO.1998.16.10.3222","article-title":"Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain","volume":"16","author":"Bruera","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/JCO.2004.03.172","article-title":"Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study","volume":"22","author":"Bruera","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD003868.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/1097-0142(19890601)63:11<2355::AID-CNCR2820631147>3.0.CO;2-#","article-title":"Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design","volume":"63","author":"Cundiff","year":"1989","journal-title":"Cancer"},{"issue":"(Suppl)","key":"10.1002\/14651858.CD003868.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0885-3924(88)90082-6","article-title":"Evaluation of a controlled- and immediate release morphine and a unique well-controlled study design in cancer pain","volume":"3","author":"Cundiff","year":"1988","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpainsymman.2006.10.011","article-title":"A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer","volume":"34","author":"Currow","year":"2007","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpainsymman.2007.12.016","article-title":"A double-blind, randomized, crossover comparison between single-dose and double-dose immediate-release oral morphine at bedtime in cancer patients","volume":"37","author":"Dale","year":"2009","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1200\/JCO.1995.13.4.1004","article-title":"Role of rectal route in treating cancer pain: a randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain","volume":"13","author":"Conno","year":"1995","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD003868.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/0959-8049(94)90166-X","article-title":"Medical therapy of malignant nerve pain. A randomised double-blind explanatory trial with naproxen versus slow-release morphine","volume":"30A","author":"Dellemijn","year":"1994","journal-title":"European Journal of Cancer"},{"issue":"7","key":"10.1002\/14651858.CD003868.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0885-3924(92)90017-C","article-title":"The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine","volume":"7","author":"Deschamps","year":"1992","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB16|cit16","first-page":"521","article-title":"Effects of controlled released morphine on quality of life for cancer pain","volume":"16","author":"Ferrell","year":"1989","journal-title":"Oncology Nursing Forum"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1200\/JCO.1993.11.5.967","article-title":"Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer","volume":"11","author":"Finn","year":"1993","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/00044011-199714030-00004","article-title":"Comparison of two oral morphine formulations for chronic severe pain of malignant and non malignant origin Kapanol (R) vs MST (R)","volume":"14","author":"Fl\u00f6ter","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003868.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2165\/00044011-199700141-00006","article-title":"Double-blind crossover clinical and pharmacokinetic comparison of oral morphine syrup and sustained release morphine sulfate capsules in patients with cancer-related pain","volume":"14","author":"Gillette","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0304-3959(96)03269-1","article-title":"Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain","volume":"69","author":"Gourlay","year":"1997","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB21|cit21","first-page":"34","article-title":"Clinical Evaluation of the analgesic effect of sustained release morphine sulfate microgranules in patients with terminal cancer","volume":"Suppl: 14","author":"Guo-Zhu","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpainsymman.2004.04.015","article-title":"Efficacy, safety, and steady state pharmacokinetics of once-a -day controlled release morphine (MS Contin XL) in cancer pain","volume":"29","author":"Hagen","year":"2005","journal-title":"Journal of Pain and Symptom Management"},{"issue":"8","key":"10.1002\/14651858.CD003868.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2044.1987.tb04107.x","article-title":"Controlled release morphine tablets: a double blind trial in patients with advanced cancer","volume":"42","author":"Hanks","year":"1987","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0885-3924(94)00067-U","article-title":"Efficacy and pharmacokinetics of a new controlled-release morphine sulfate 200-mg tablet","volume":"10","author":"Hanks","year":"1995","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-684X-7-17","article-title":"A randomized, double-blind comparison of OROS hydromorphone and controlled-release morphine for the control of chronic cancer pain","volume":"7","author":"Hanna","year":"2008","journal-title":"BMC Palliative Care"},{"key":"10.1002\/14651858.CD003868.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1191\/0269216303pm695oa","article-title":"Intravenous morphine for rapid control of severe cancer pain","volume":"17","author":"Harris","year":"2003","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD003868.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3959(97)00072-9","article-title":"Controlled-release oxycodone and morphine in cancer related pain","volume":"73","author":"Heiskanen","year":"1997","journal-title":"Pain"},{"issue":"8","key":"10.1002\/14651858.CD003868.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/02841860050215927","article-title":"Morphine or oxycodone in cancer pain?","volume":"39","author":"Heiskanen","year":"2000","journal-title":"Acta Oncologica"},{"key":"10.1002\/14651858.CD003868.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1049909109345146","article-title":"A comparative study of 2 sustained-release morphine preparations for pain in advanced cancer","volume":"27","author":"Homsi","year":"2010","journal-title":"American Journal of Hospice and Palliative Care"},{"issue":"11","key":"10.1002\/14651858.CD003868.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1365-2044.1989.tb09143.x","article-title":"Controlled release morphine in cancer pain. Is a loading dose required when the formulation is changed?","volume":"44","author":"Hoskin","year":"1989","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/clpt.1990.85","article-title":"Morphine and oxycodone hydrochloride in the management of cancer pain","volume":"47","author":"Kalso","year":"1990","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00044011-200019010-00004","article-title":"A patient preference study comparing two extended-release morphine sulfate formulations (once-daily Kadian\u2122 versus twice-daily MS Contin\u2122 for cancer pain","volume":"19","author":"Kerr","year":"2000","journal-title":"Clinical Drug Investigation"},{"issue":"1-2","key":"10.1002\/14651858.CD003868.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3959(02)00328-7","article-title":"Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial","volume":"101","author":"Klepstad","year":"2003","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub3-BIB34|cit34","series-title":"Advances in Cancer Pain Management. The International Symposium on Pain Control","article-title":"Controlled evaluation and ongoing experience with sustained release morphine in patients with advanced cancer pain","author":"Henriksen","year":"1986"},{"issue":"9","key":"10.1002\/14651858.CD003868.pub3-BIB35|cit35","first-page":"780","article-title":"Slow-release morphine tablets compared with conventional morphine tablets in the treatment of cancer pain","volume":"147","author":"Knudsen","year":"1985","journal-title":"Ugeskr Laeger"},{"key":"10.1002\/14651858.CD003868.pub3-BIB36|cit36","first-page":"73","article-title":"Modern aspects of morphine therapy","volume-title":"Advances in Morphine Therapy. The 1983 International Symposium on Pain Control. Royal Society of Medicine International Congress and Symposium Series no 64","author":"Kossman","year":"1983"},{"issue":"11","key":"10.1002\/14651858.CD003868.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/sj.bjc.6601365","article-title":"Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients","volume":"89","author":"Lauretti","year":"2003","journal-title":"British Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB38|cit38","first-page":"257","article-title":"Analgesic efficacy and side effects of oral tramadol and morphine administered orally in the treatment of cancer pain","volume":"51","author":"Leppart","year":"2001","journal-title":"Nowotwory"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB39|cit39","first-page":"435","article-title":"The Brompton mixture versus morphine solution given orally: effects on pain","volume":"120","author":"Melzack","year":"1979","journal-title":"Canadian Medical Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0885-3924(98)80004-3","article-title":"Dextropropoxyphene versus morphine in opioid-naive cancer patients with pain","volume":"15","author":"Mercadante","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejpain.2008.01.013","article-title":"Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management","volume":"12","author":"Mercadante","year":"2008","journal-title":"European Journal of Pain"},{"issue":"9","key":"10.1002\/14651858.CD003868.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/AJP.0b013e3181ecd895","article-title":"Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study","volume":"26","author":"Mercadante","year":"2010","journal-title":"Clinical Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0885-3924(95)00063-5","article-title":"Control of cancer-related pain with MS Contin: a comparison between 12-hourly and 8-hourly administration","volume":"10","author":"Mignault","year":"1995","journal-title":"Journal of Pain and Symptom Management"},{"issue":"11","key":"10.1002\/14651858.CD003868.pub3-BIB44|cit44","first-page":"2357","article-title":"Utility evaluation of morphine hydrocloride suppository, AN-631, in the treatment of cancer pain","volume":"6","author":"Mizuguchi","year":"1990","journal-title":"Rinshou Igaku"},{"key":"10.1002\/14651858.CD003868.pub3-BIB45|cit45","first-page":"1","article-title":"A randomised crossover comparison of controlled release hydromorphone tablets with controlled release morphine tablets in patients with cancer pain","volume":"2","author":"Moriarty","year":"1999","journal-title":"Journal of Clinical Research"},{"key":"10.1002\/14651858.CD003868.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1090-3801(98)90020-9","article-title":"Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: A randomized, double-blind, parallel-group study","volume":"2","author":"Mucci LoRusso","year":"1998","journal-title":"European Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/026921639701100608","article-title":"A randomized crossover study comparing the efficacy and tolerability of a novel once-daily morphine preparation (MXL capsules) with MST Continus tablets in cancer patients with severe pain","volume":"11","author":"O'Brien","year":"1997","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD003868.pub3-BIB48|cit48","first-page":"20","article-title":"Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer","volume":"20","author":"Ozt\u00fcrk","year":"2008","journal-title":"Agri"},{"issue":"12","key":"10.1002\/14651858.CD003868.pub3-BIB49|cit49","first-page":"672","article-title":"Comparison of morphine slow release tablet (MST) and morphine sulphate solution (MSS) in the treatment of cancer pain","volume":"76","author":"Panich","year":"1993","journal-title":"Journal of Medical Association of Thailand"},{"issue":"Suppl: 11","key":"10.1002\/14651858.CD003868.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1002\/1097-0142(19890601)63:11<2284::AID-CNCR2820631137>3.0.CO;2-3","article-title":"Oral controlled release morphine sulfate. Analgesic efficacy and side effects of a 100 mg tablet in cancer pain patients","volume":"63","author":"Portenoy","year":"1989","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"Suppl: 16","DOI":"10.1016\/0885-3924(88)90076-0","article-title":"Controlled-release morphine sulfate: analgesic efficacy and side effects of a 100 mg tablet","volume":"3","author":"Portenoy","year":"1988","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jpainsymman.2009.08.013","article-title":"Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study","volume":"39","author":"Ridgway","year":"2010","journal-title":"Journal of Pain and Symptom Management"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0959-8049(94)90524-X","article-title":"Efficacy and tolerance of oral dipyrone versus oral morphine for cancer pain","volume":"30A","author":"Rodriguez","year":"1994","journal-title":"European Journal of Cancer"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003868.pub3-BIB54|cit54","first-page":"S55","article-title":"Morphine at gramme doses: kinetics, dynamics and clinical need","volume":"67","author":"Smith","year":"1991","journal-title":"Postgraduate Medical Journal"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD003868.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/1097-0142(19890601)63:11<2275::AID-CNCR2820631136>3.0.CO;2-4","article-title":"Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients","volume":"63","author":"Thirlwell","year":"1989","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD003868.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1191\/0269216302pm591oa","article-title":"An assessment of the efficacy and tolerability of a 'double dose' of normal-release morphine sulphate at bedtime.","volume":"16","author":"Todd","year":"2002","journal-title":"Palliative Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003868.pub3-BIB57|cit57","first-page":"58","article-title":"The measurement of pain in terminal carcinoma","volume":"4","author":"Twycross","year":"1976","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD003868.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0304-3959(77)90072-0","article-title":"Choice of strong analgesic in terminal cancer: diamorphine or morphine?","volume":"3","author":"Twycross","year":"1977","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1399-6576.1988.tb02711.x","article-title":"Opioid treatment for radiating cancer pain: oral administration vs. epidural techniques","volume":"32","author":"Vainio","year":"1988","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1185\/030079903125002045","article-title":"Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain","volume":"19","author":"Seventer","year":"2003","journal-title":"Current Medical Research and Opinion"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0885-3924(86)80042-2","article-title":"A randomized study on oral administration of morphine and methadone in the treatment of cancer pain","volume":"1","author":"Ventafridda","year":"1986","journal-title":"Journal of Pain and Symptom Management"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0885-3924(89)90005-5","article-title":"Clinical observations on controlled release morphine in cancer pain","volume":"4","author":"Ventafridda","year":"1989","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB63|cit63","first-page":"137","article-title":"Sustained release morphine in cancer pain","volume":"9","author":"Vielvoye-Kerkmeer","year":"2002","journal-title":"European Journal of Palliative Care"},{"key":"10.1002\/14651858.CD003868.pub3-BIB64|cit64","first-page":"99","article-title":"A controlled study of MST Continus tablets for chronic pain in advanced cancer","volume-title":"Advances in Morphine Therapy: International Symposium on Pain Control","author":"Walsh","year":"1984"},{"key":"10.1002\/14651858.CD003868.pub3-BIB65|cit65","first-page":"727","article-title":"Clinical evaluation of slow release morphine tablets","volume":"9","author":"Walsh","year":"1985","journal-title":"Advances in Pain Research and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB66|cit66","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00000421-199206000-00018","article-title":"A controlled study of sustained-release morphine sulfate tablets in chronic pain from advanced cancer","volume":"15","author":"Walsh","year":"1992","journal-title":"American Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/oxfordjournals.annonc.a058765","article-title":"Oral tramadol, a mu-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain","volume":"5","author":"Wilder-Smith","year":"1994","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00685556","article-title":"Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients","volume":"31","author":"Wilkinson","year":"1992","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB69|cit69","first-page":"25","article-title":"Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain","volume":"35","author":"Wong","year":"1997","journal-title":"Acta Anaesthesiologica Sinica"},{"issue":"7","key":"10.1002\/14651858.CD003868.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0885-3924(92)90019-E","article-title":"Pharmacokinetics of two novel rectal controlled-release morphine formulations","volume":"7","author":"Babul","year":"1992","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/009127007701700402","article-title":"Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer","volume":"17","author":"Beaver","year":"1977","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB72|cit72","first-page":"92","article-title":"Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone","volume":"207","author":"Beaver","year":"1978","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB73|cit73","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00002508-199412000-00012","article-title":"Comparison of morphine and ketorolac for intravenous patient-controlled analgesia in postoperative cancer patients","volume":"10","author":"Bosek","year":"1994","journal-title":"Clinical Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB74|cit74","first-page":"275","article-title":"Principles of cancer pain management. Use of long-acting oral morphine","volume":"28","author":"Brooks","year":"1989","journal-title":"Journal of Family Practice"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00044011-199714020-00008","article-title":"Comparative bioavailability of sustained-release morphine sulfate capsules versus pellets","volume":"14","author":"Broomhead","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub3-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1200\/JCO.1995.13.6.1520","article-title":"Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation","volume":"13","author":"Bruera","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003868.pub3-BIB77|cit77","first-page":"132","article-title":"A comparison of morphine sulphate solution and MST Continus tablets in the treatment of pain in terminally ill at home","volume-title":"International Symposium on Pain Control. Royal Society of Medicines Services International Congress and Symposium Series 123","author":"Buxton","year":"1987"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB78|cit78","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/j.1875-9114.1990.tb02577.x","article-title":"A multiinstitutional evaluation of the analgesic efficacy and safety of ketorolac tromethamine, acetaminophen plus codeine, and placebo in cancer pain","volume":"10","author":"Carlson","year":"1990","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub3-BIB79|cit79","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.44.5.857","article-title":"Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies","volume":"44","author":"Cherny","year":"1994","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003868.pub3-BIB80|cit80","doi-asserted-by":"crossref","first-page":"Suppl: 29","DOI":"10.1213\/00000539-198702001-00029","article-title":"Morphine inhalation versus intravenous infusion in pain treatment after abdominal surgery","volume":"66","author":"Chrubasik","year":"1987","journal-title":"Anesthesia and Analgesia"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub3-BIB81|cit81","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/07357909209024792","article-title":"Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use","volume":"10","author":"Citron","year":"1992","journal-title":"Cancer Investigation"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB82|cit82","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0893-133X(95)00205-R","article-title":"Effects of oral morphine on cold pressor tolerance time and neuropsychological performance","volume":"15","author":"Cleeland","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"1-2","key":"10.1002\/14651858.CD003868.pub3-BIB83|cit83","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3959(00)00427-9","article-title":"Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR)","volume":"91","author":"Coluzzi","year":"2001","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB84|cit84","first-page":"26","article-title":"Breakthrough cancer pain: A randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR)","volume":"3","author":"Coluzzi","year":"2002","journal-title":"Douleurs"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub3-BIB85|cit85","first-page":"306","article-title":"Irruptive pain in cancer: A randomized comparative trial of oral transmucosal fentanyl citrate (OTFC) versus immediate-release morphine sulphate (MSIR)","volume":"9","author":"Coluzzi","year":"2002","journal-title":"Revista De La Sociedad Espanola Del Dolor"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB86|cit86","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0360-3016(97)00076-X","article-title":"Low energy helium-neon laser in the prevention of oral mucositis in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial","volume":"38","author":"Cowen","year":"1997","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB87|cit87","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1300\/J011v09n01_07","article-title":"Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer","volume":"9","author":"Davis","year":"1993","journal-title":"Hospice Journal"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003868.pub3-BIB88|cit88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2165\/00044011-199700141-00007","article-title":"Randomised crossover comparison of the pharmacokinetic profiles of two sustained release morphine sulfate formulations in patients with cancer-related pain","volume":"14","author":"Bernardi","year":"1997","journal-title":"Clinical Drug Investigation"},{"key":"10.1002\/14651858.CD003868.pub3-BIB89|cit89","first-page":"49","article-title":"Analgesic efficacy and side effects of opioids in different routes of administration for terminal cancer patients: A clinical, pharmacokinetic and neurophysiological study","volume":"13","author":"Conno","year":"1997","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub3-BIB90|cit90","first-page":"356","article-title":"The steady-state concentration of morphine sulphate tablets and its clinical analgesic effect in cancer patients","volume":"32","author":"Deng","year":"1997","journal-title":"Chinese Pharmaceutical Journal"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB91|cit91","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0885-3924(97)00361-8","article-title":"Long-term treatment of cancer pain with transdermal fentanyl","volume":"15","author":"Donner","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub3-BIB92|cit92","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3959(89)90020-1","article-title":"Treatment of severe cancer pain by low-dose continuous subcutaneous morphine","volume":"36","author":"Drexel","year":"1989","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub3-BIB93|cit93","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00007691-199904000-00011","article-title":"The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories","volume":"21","author":"Du","year":"1999","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1002\/14651858.CD003868.pub3-BIB94|cit94","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jpainsymman.2006.09.017","article-title":"A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients","volume":"33","author":"Dudgeon","year":"2007","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB95|cit95","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0885-3924(92)90101-M","article-title":"A double-blind, crossover trial of intravenous clodronate in metastatic bone pain","volume":"7","author":"Ernst","year":"1992","journal-title":"Journal of Pain and Symptom Management"},{"issue":"8","key":"10.1002\/14651858.CD003868.pub3-BIB96|cit96","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jnci\/90.8.611","article-title":"Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients","volume":"90","author":"Farrar","year":"1998","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub3-BIB97|cit97","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0885-3924(95)00148-4","article-title":"Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain","volume":"11","author":"Faura","year":"1996","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB98|cit98","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/026921639300700407","article-title":"A novel morphine sulphate preparation: clinical trial of a controlled-release morphine suspension in cancer pain","volume":"7","author":"Forman","year":"1993","journal-title":"Palliative Medicine"},{"issue":"7","key":"10.1002\/14651858.CD003868.pub3-BIB99|cit99","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/000348940010900711","article-title":"Cervical versus thoracic epidural morphine for the treatment of head and neck cancer pain","volume":"109","author":"Georgiou","year":"2000","journal-title":"Annals of Otology, Rhinology & Laryngology"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub3-BIB100|cit100","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1200\/JCO.1993.11.5.973","article-title":"Dose-ranging study of oxycodone for chronic pain in advanced cancer","volume":"11","author":"Glare","year":"1993","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB101|cit101","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0304-3959(86)90234-4","article-title":"A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer","volume":"25","author":"Gourlay","year":"1986","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB102|cit102","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0304-3959(94)00204-R","article-title":"Chronopharmacokinetic variability in plasma morphine concentrations following oral doses of morphine solution","volume":"61","author":"Gourlay","year":"1995","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub3-BIB103|cit103","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/026921639000400307","article-title":"Evaluation of the palatability of Oramorph - a proprietary preparation of oral morphine sulphate","volume":"4","author":"Griffith","year":"1990","journal-title":"Palliative Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB104|cit104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/j.1552-4604.1995.tb04743.x","article-title":"Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone","volume":"35","author":"Hagen","year":"1995","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003868.pub3-BIB105|cit105","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0304-3959(84)90730-9","article-title":"Controlled release morphine tablets in chronic cancer pain","volume":"Suppl","author":"Hanks","year":"1984","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub3-BIB106|cit106","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF00279975","article-title":"Single dose and steady state kinetics of morphine and its metabolites in cancer patients - a comparison of two oral formulations","volume":"40","author":"Hasselstrom","year":"1991","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub3-BIB107|cit107","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3959(90)90062-I","article-title":"Self-administration of morphine in bone marrow transplant patients reduces drug requirement","volume":"40","author":"Hill","year":"1990","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB108|cit108","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0304-3959(92)90235-4","article-title":"Patient-controlled analgesic infusions: alfentanil versus morphine","volume":"49","author":"Hill","year":"1992","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub3-BIB109|cit109","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/07357909709047595","article-title":"A pharmacodynamic study of morphine and its glucuronide metabolites after single morphine dosing in cancer patients with pain","volume":"15","author":"Hoffman","year":"1997","journal-title":"Cancer Investigation"},{"key":"10.1002\/14651858.CD003868.pub3-BIB110|cit110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0304-3959(81)90506-6","article-title":"Analgesic assay of oral zomepirac and intramuscular morphine in advanced cancer patients","volume":"Suppl","author":"Houde","year":"1981","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub3-BIB111|cit111","first-page":"254","article-title":"Relative analgesic potency of intramuscular heroin and morphine in cancer patients with postoperative pain: a preliminary report","volume":"27","author":"Kaiko","year":"1979","journal-title":"National Institute on Drug Abuse Research Monograph"},{"key":"10.1002\/14651858.CD003868.pub3-BIB112|cit112","first-page":"205","article-title":"Oral fenoprofen compared to intramuscular morphine and oral aspirin in cancer patients with postoperative pain","volume":"49","author":"Kaiko","year":"1984","journal-title":"National Institute on Drug Abuse Research Monograph"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB113|cit113","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0304-3959(87)90004-2","article-title":"Cocaine and morphine interaction in acute and chronic cancer pain","volume":"31","author":"Kaiko","year":"1987","journal-title":"Pain"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD003868.pub3-BIB114|cit114","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1002\/1097-0142(19890601)63:11<2348::AID-CNCR2820631146>3.0.CO;2-V","article-title":"The United States experience with oral controlled release morphine (MS Contin tablets). Parts I and II. Review of nine dose titration studies and clinical pharmacology of 15 mg, 30 mg, 60 mg, and 100 mg tablet strengths in normal subjects","volume":"63","author":"Kaiko","year":"1989","journal-title":"Cancer"},{"issue":"2-3","key":"10.1002\/14651858.CD003868.pub3-BIB115|cit115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0304-3959(96)03161-2","article-title":"Epidural and subcutaneous morphine in the management of cancer pain: A double-blind cross-over study","volume":"67","author":"Kalso","year":"1996","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub3-BIB116|cit116","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.1987.5.6.956","article-title":"Controlled release oral morphine sulfate in the treatment of cancer pain with pharmacokinetic correlation","volume":"5","author":"Khojasteh","year":"1987","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB117|cit117","first-page":"259","article-title":"Preemptive analgesia on postmastectomy pain syndrome with ibuprofen-arginine","volume":"84","author":"Lakdja","year":"1997","journal-title":"Bulletin Du Cancer"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub3-BIB118|cit118","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/00000542-199906000-00005","article-title":"Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management","volume":"90","author":"Lauretti","year":"1999","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB119|cit119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J011v06n04_01","article-title":"A multi investigator clinical evaluation of oral controlled release morphine (MS Contin tablets) administered to cancer patients","volume":"6","author":"Lazarus","year":"1990","journal-title":"Hospice Journal"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB120|cit120","first-page":"289","article-title":"Combined traditional Chinese medicine and Western medicine. Relieving effects of Chinese herbs, ear-acupuncture and epidural morphine on postoperative pain in liver cancer","volume":"107","author":"Li","year":"1994","journal-title":"Chinese Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub3-BIB121|cit121","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpainsymman.2003.10.006","article-title":"Use of strong opioids in advanced cancer pain: a randomized trial","volume":"27","author":"Marinangeli","year":"2004","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB122|cit122","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/cs0880447","article-title":"Effects of inhaled nebulized morphine on ventilation and breathlessness during exercise in healthy man","volume":"88","author":"Masood","year":"1995","journal-title":"Clinical Science"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB123|cit123","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2125.1996.tb00192.x","article-title":"Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects","volume":"41","author":"Masood","year":"1996","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub3-BIB124|cit124","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/j.1552-4604.1987.tb02177.x","article-title":"Management of cancer pain with oral controlled-release morphine sulfate","volume":"27","author":"Meed","year":"1987","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub3-BIB125|cit125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-3959(89)90021-3","article-title":"Double-blind evaluation of analgesic efficacy of orally administered diclofenac, nefopam, and acetylsalicylic acid (ASA) plus codeine in chronic cancer pain","volume":"36","author":"Minotti","year":"1989","journal-title":"Pain"},{"issue":"2-3","key":"10.1002\/14651858.CD003868.pub3-BIB126|cit126","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3959(97)00157-7","article-title":"Double-blind evaluation of short-term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain","volume":"74","author":"Minotti","year":"1998","journal-title":"Pain"},{"issue":"12","key":"10.1002\/14651858.CD003868.pub3-BIB127|cit127","first-page":"576","article-title":"Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo","volume":"30","author":"Morgan","year":"1992","journal-title":"International Journal of Clinical Pharmacology,Therapy and Toxicology"},{"issue":"8995","key":"10.1002\/14651858.CD003868.pub3-BIB128|cit128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(96)90339-6","article-title":"Randomised trial of oral morphine for chronic non-cancer pain","volume":"347","author":"Moulin","year":"1996","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB129|cit129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3959(92)90182-B","article-title":"Octreotide: a potent new non-opiate analgesic for intrathecal infusion","volume":"49","author":"Penn","year":"1992","journal-title":"Pain"},{"issue":"2-3","key":"10.1002\/14651858.CD003868.pub3-BIB130|cit130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3959(98)00179-1","article-title":"Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study","volume":"79","author":"Portenoy","year":"1999","journal-title":"Pain"},{"issue":"10","key":"10.1002\/14651858.CD003868.pub3-BIB131|cit131","first-page":"91","article-title":"Tramadol and the possibilities for its use with cancer patients","volume":"64","author":"Repas","year":"1992","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1002\/14651858.CD003868.pub3-BIB132|cit132","first-page":"397","article-title":"Rectal versus oral morphine for the management of cancer pain. A double-blind, double dummy cross-over trial","volume-title":"Proceedings of the Annual Meeting of the American Society of Clinical Oncology","author":"Ripamonti","year":"1992"},{"key":"10.1002\/14651858.CD003868.pub3-BIB133|cit133","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(96)03186-7","article-title":"Nimodipine fails to enhance the analgesic effect of slow release morphine in the early phases of cancer pain treatment","volume":"68","author":"Roca","year":"1996","journal-title":"Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD003868.pub3-BIB134|cit134","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3959(98)00019-0","article-title":"Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: a double-blind, placebo-controlled study.","volume":"76","author":"Santillan","year":"1998","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB135|cit135","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/clpt.1988.46","article-title":"Rescue factor: A design for evaluating long-acting analgesics","volume":"43","author":"Savarese","year":"1988","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD003868.pub3-BIB136|cit136","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF00609900","article-title":"Steady-state kinetics and analgesic effect of oral morphine in cancer patients","volume":"24","author":"S\u00e4we","year":"1983","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"11","key":"10.1002\/14651858.CD003868.pub3-BIB137|cit137","first-page":"689","article-title":"Intrathecal morphine for postoperative pain","volume":"41","author":"Schaer","year":"1992","journal-title":"Anaesthesist"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB138|cit138","first-page":"25","article-title":"High-dose epidural opioid treatment of malignant pain","volume":"151","author":"Sjogren","year":"1989","journal-title":"Ugeskrift Laeger"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub3-BIB139|cit139","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0885-3924(98)00044-X","article-title":"A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain","volume":"16","author":"Sloan","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub3-BIB140|cit140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0304-3959(81)90320-1","article-title":"Comparison of the analgesic effect of parenteral levonantradol to morphine and placebo in patients with moderate to severe pain of cancer","volume":"Suppl","author":"Stambaugh","year":"1981","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub3-BIB141|cit141","first-page":"838","article-title":"Comparison of immediate vs. sustained released oral morphine in cancer patients - acute pain novel study design","volume":"30","author":"Stambaugh","year":"1990","journal-title":"Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub3-BIB142|cit142","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1177\/00912700122010375","article-title":"Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients. 41","volume":"41","author":"Stambaugh","year":"2001","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub3-BIB143|cit143","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/026921639601000208","article-title":"An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer","volume":"10","author":"Sykes","year":"1996","journal-title":"Palliative Medicine"},{"issue":"17","key":"10.1002\/14651858.CD003868.pub3-BIB144|cit144","first-page":"6889","article-title":"A clinical evaluation of S-8114 (morphine sulphate controlled-release tablets) in the management of cancer pain: comparison with oral morphine hydrochloride","volume":"21","author":"Takeda","year":"1987","journal-title":"Kiso to Rinsho (The Clinical Report)"},{"key":"10.1002\/14651858.CD003868.pub3-BIB145|cit145","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.1016\/0304-3959(90)92870-V","article-title":"Tramadol hydrochloride in the relief of cancer pain. A double blind comparison against sustained release morphine","volume":"Suppl","author":"Tawfik","year":"1990","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB146|cit146","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/j.1552-4604.1980.tb01705.x","article-title":"Relative analgesic potency of oral zomepirac and intramuscular morphine in cancer patients with postoperative pain","volume":"20","author":"Wallenstein","year":"1980","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003868.pub3-BIB147|cit147","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/0304-3959(84)90432-9","article-title":"Controlled study of slow release morphine for chronic pain in advanced cancer","volume":"Suppl","author":"Walsh","year":"1984","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub3-BIB148|cit148","first-page":"Abs No 1035","article-title":"Controlled study of oral slow release morphine in pain due to advanced cancer","volume-title":"Proceedings of the Annual Meeting of the American Society of Clinical Onclogy","volume":"9","author":"Walsh","year":"1985"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub3-BIB149|cit149","first-page":"53","article-title":"Analgesia with oral narcotics and added ibuprofen in cancer patients","volume":"4","author":"Weingart","year":"1985","journal-title":"Clinical Pharmacy"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub3-BIB150|cit150","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00007691-199310000-00003","article-title":"Morphine pharmacokinetics and effects on salivation and continuous reaction times in healthy volunteers","volume":"15","author":"Westerling","year":"1993","journal-title":"Therapeutic Drug Monitoring"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub3-BIB151|cit151","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/0269216310392102","article-title":"Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project","volume":"25","author":"Caraceni","year":"2011","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD003868.pub3-BIB152|cit152","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0885-3924(98)00094-3","article-title":"Peak plasma concentrations after oral morphine - a systematic review","volume":"16","author":"Collins","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub3-BIB153|cit153","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003868.pub3-BIB154|cit154","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0304-3959(97)00142-5","article-title":"Systematic review of factors affecting the ratios of morphine and its major metabolites","volume":"74","author":"Faura","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub3-BIB155|cit155","unstructured":"Goudas L Carr DB Bloch R Balk E Ioannides JP Terrin N Management of cancer pain Evidence report\/Technology Assessment No 35 ARHQ Publication No 02-E002. Rockville MD 2001"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD003868.pub3-BIB156|cit156","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/1097-0142(19890601)63:11<2294::AID-CNCR2820631139>3.0.CO;2-X","article-title":"Analgesic response to single and multiple doses of controlled release morphine tablets and morphine oral solution in cancer patients","volume":"63","author":"Goughnour","year":"1989","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD003868.pub3-BIB157|cit157","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780192632340.001.0001","volume-title":"Oxford Textbook of Clinical Pharmacology and Drug Therapy","author":"Grahame-Smith","year":"2002"},{"issue":"12","key":"10.1002\/14651858.CD003868.pub3-BIB158|cit158","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010270","article-title":"Transdermal fentanyl for cancer pain","author":"Hadley","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003868.pub3-BIB159|cit159","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3959(97)00072-9","article-title":"Controlled-release oxycodone and morphine in cancer related pain","volume":"73","author":"Heiskanen","year":"1997","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub3-BIB160|cit160","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003868.pub3-BIB161|cit161","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0304-3959(96)03033-3","article-title":"Developing a database of published reports of randomised clinical trials in pain research","volume":"66","author":"Jadad","year":"1996","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub3-BIB162|cit162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB163|cit163","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"issue":"7","key":"10.1002\/14651858.CD003868.pub3-BIB164|cit164","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain--establishing best practice in the reporting of systematic reviews","volume":"14","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub3-BIB165|cit165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"12","key":"10.1002\/14651858.CD003868.pub3-BIB166|cit166","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB167|cit167","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD003868.pub3-BIB168|cit168","doi-asserted-by":"crossref","first-page":"c 3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003868.pub3-BIB169|cit169","volume-title":"Martindale. The complete drug reference","author":"Parfitt","year":"1999"},{"key":"10.1002\/14651858.CD003868.pub3-BIB170|cit170","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(99)01310-0","article-title":"Management of cancer pain","volume":"353","author":"Portenoy","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub3-BIB171|cit171","article-title":"Hydromorphone for acute and chronic pain","author":"Quigley","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003868.pub3-BIB172|cit172","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"key":"10.1002\/14651858.CD003868.pub3-BIB173|cit173","volume-title":"History of Pain","author":"Rey","year":"1993"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub3-BIB174|cit174","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003870.pub6","article-title":"Oxycodone for cancer-related pain","author":"Schmidt-Hansen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003868.pub3-BIB175|cit175","volume-title":"Cancer Pain Relief","year":"1986"},{"key":"10.1002\/14651858.CD003868.pub3-BIB176|cit176","unstructured":"World Health Organization WHO Essential Medicines List 17th Edition whqlibdoc.who.int\/hq\/2011\/a95053_eng.pdf"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003868.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T00:00:00Z","timestamp":1461283200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003868.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T07:19:05Z","timestamp":1715757545000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003868.pub3"}},"subtitle":[],"editor":[{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,23]]},"references-count":176,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003868.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD003868.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2013,7,23]]}}}